COMMUNIQUÉS West-GlobeNewswire

SELLAS Life Sciences Group Announces Notice of Allowance from U.S. Patent and Trademark Office for New Patent Covering Composition of Matter for WT-1 Peptides
15/03/2018
NEW YORK, March 15, 2018 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS ) (“SELLAS” or the “Company”), a clinical-stage biopharmaceutical company focused on novel cancer immunotherapies for a broad [...]
Abeona Therapeutics Receives FDA Rare Pediatric Disease Designation for ABO-202 Gene Therapy Program in CLN1 Disease
15/03/2018
NEW YORK and CLEVELAND, March 15, 2018 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (NASDAQ: ABEO ), a leading clinical-stage biopharmaceutical company focused on developing novel cell and gene therapies for life- [...]
Marrone Bio Innovations Announces Zequanox® Distribution Partnership
15/03/2018
DAVIS, Calif., March 15, 2018 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII ) (MBI), a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental [...]
Sport Endurance Wholly-Owned Subsidiary, Yield Endurance, Enters into Note Purchase Agreement for Gross Proceeds of $5 Million in Bitcoin
15/03/2018
JERSEY CITY, N.J., March 15, 2018 (GLOBE NEWSWIRE) -- Sport Endurance, Inc. (OTCQB:SENZ) (the “Company”) and its wholly-owned subsidiary, Yield Endurance, Inc., today announced entering into a note purchase agreement [...]
Innovation Pharmaceuticals Views Brilacidin-OM as Clearly Differentiated Compared to Limited Competition for Preventing Severe Oral Mucositis
15/03/2018
BEVERLY, Mass., March 15, 2018 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals, (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, is pleased to provide shareholders with a status report on the [...]
Agritek Holdings, Inc. Announces Plans For Purchase Of New 15,000 Sq. ft. Cultivation And Manufacturing Facility In San Juan, Puerto Rico With Partner 1919 Clinic
15/03/2018
LOS ANGELES, CA, March 15, 2018 (GLOBE NEWSWIRE) -- Agritek Holdings, Inc. (OTCQB: AGTK) www.AgritekHoldings.com , a fully integrated, active real estate investor for the cannabis sector and consultant for multiple [...]
Minerva Neurosciences to Host Key Opinion Leader Meeting on the Negative Symptoms of Schizophrenia on Thursday, March 22
15/03/2018
WALTHAM, Mass., March 15, 2018 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV ), a biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) disorders, today [...]
BioCorRx Provides Update on New Weight Management Program
15/03/2018
ANAHEIM, CA, March 15, 2018 (GLOBE NEWSWIRE) -- BioCorRx Inc. (OTCQB: BICX) (the "Company"), a developer and provider of advanced solutions in the treatment of alcohol and opioid addictions, today announced an update on [...]
Organovo to Present at H.C. Wainwright Nash Investor Conference
15/03/2018
SAN DIEGO, March 15, 2018 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ: ONVO ) (“Organovo”) today announced that Chief Executive Officer Taylor J. Crouch is scheduled to speak at the H.C. Wainwright NASH Investor [...]
Midatech announces changes in Senior Management Team
15/03/2018
15 March 2018 Midatech Pharma PLC ("Midatech" or the "Company") Midatech announces changes in Senior Management Team Midatech (AIM: MTPH, Nasdaq: MTP), the international specialty pharmaceutical company focused on [...]
Endocyte Nominates Dawn Svoronos for Election to Its Board of Directors and Announces Other Board Developments
15/03/2018
WEST LAFAYETTE, Ind., March 15, 2018 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq: ECYT ), a biopharmaceutical company developing targeted therapeutics for personalized cancer treatment, today announced the nomination of [...]
Verona Pharma to Present at Upcoming Healthcare Investor Conferences
15/03/2018
LONDON, March 15, 2018 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (Nasdaq: VRNA ) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for [...]
Matinas BioPharma to Present at the Oppenheimer 28th Annual Healthcare Conference
15/03/2018
BEDMINSTER, N.J., March 15, 2018 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE MKT:MTNB), a clinical-stage biopharmaceutical company focused on developing innovative anti-infectives for orphan indications, [...]
Caladrius Biosciences to Host Fourth Quarter and Year End 2017 Financial Results Conference Call on Thursday, March 22, 2018 at 4:30 p.m. Eastern Time
15/03/2018
BASKING RIDGE, N.J., March 15, 2018 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS ) (“Caladrius” or the “Company”), a development-stage biopharmaceutical company with multiple technology platforms [...]
IBEX Reports Results for the Second Quarter and the Six Months Ended January 31, 2018
15/03/2018
MONTREAL, March 15, 2018 (GLOBE NEWSWIRE) -- IBEX Technologies Inc. (“IBEX” or the “Company”) (TSX Venture:IBT) today reported its financial results for the six months ended January 31, 2018. “As anticipated, the [...]
Onconova Therapeutics to Present Data on a First-in-class Dual Inhibitor of CDK4/6 + ARK5 at the American Association for Cancer Research Annual Meeting 2018
15/03/2018
NEWTOWN, Pa., March 15, 2018 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX ), a Phase 3-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, with a [...]
BeyondSpring Chief Medical Officer Presents at Three Prominent Industry Conferences in March 2018
15/03/2018
NEW YORK, March 15, 2018 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI ), a global clinical-stage biopharmaceutical company focused on the development of transforming immuno-oncology cancer therapies, today [...]
Cellectar Announces Late-Breaking Poster Presentations at AACR 2018 Featuring PDCs and CLR 131
15/03/2018
MADISON, Wis., March 15, 2018 (GLOBE NEWSWIRE) -- Cellectar Biosciences (Nasdaq: CLRB ), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment [...]
Selecta Biosciences Announces Fourth Quarter and Year End 2017 Financial Results and Provides Corporate Update
15/03/2018
SEL-212 Severe Gout Program on Track; Additional Phase 2 Data for Higher Dose Cohorts to be Presented on April 9 th or 10 th , 2018 at PANLAR Congress Phase 1 Clinical Trial of SEL-403 for Mesothelioma Initiated Company [...]

Pages